This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tagcyx Biotechnologies. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Iwao Nozawa: Innovator in Nucleic Acid Stabilization
Introduction
Iwao Nozawa is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of biotechnology, particularly in the stabilization of functional nucleic acids. His innovative approach aims to enhance the resistance of nucleic acid fragments to degradation, which is crucial for various applications in molecular biology.
Latest Patents
Iwao Nozawa holds a patent for a "Stabilization method of functional nucleic acid." This invention is designed to improve the resistance of single- or double-stranded nucleic acid fragments to degradation by nucleolytic enzymes. The method is both simple and cost-effective, making it accessible for widespread use. The nucleic acid fragment includes hairpin-shaped DNA that comprises specific nucleic acid regions, enhancing its stability and functionality.
Career Highlights
Iwao Nozawa is associated with Tagcyx Biotechnologies, where he continues to develop innovative solutions in biotechnology. His work focuses on creating methods that can significantly impact research and therapeutic applications involving nucleic acids. His dedication to advancing this field is evident through his patent and ongoing research efforts.
Collaborations
Iwao Nozawa collaborates with esteemed colleagues, including Ichiro Hirao and Michiko Hirao. Their combined expertise contributes to the advancement of biotechnology and the development of new methodologies in nucleic acid research.
Conclusion
Iwao Nozawa's contributions to the stabilization of functional nucleic acids represent a significant advancement in biotechnology. His innovative patent and collaborative efforts highlight his commitment to enhancing the field. His work will likely continue to influence future research and applications in molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile